https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36437 Wed 23 Feb 2022 16:02:31 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14301 Wed 11 Apr 2018 12:34:58 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14167 Wed 11 Apr 2018 10:41:11 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:15216 Wed 11 Apr 2018 09:45:45 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19319 55 years) with obstructive airway disease and healthy controls (N=56) underwent inhaler technique assessment, skin allergy testing, venepuncture, fractional exhaled nitric oxide (FENO) and gas diffusion measurement, exercise testing, sputum induction, and questionnaire assessment. They then completed an assessment burden questionnaire across five domains: difficulty, discomfort, pain, symptoms and test duration. Results: Test perception was generally favourable. Induced sputum had the greatest test burden perceived as being more difficult (mean 0.83, P=0.001), associated with more discomfort (mean 1.3, P<0.001), more painful (0.46, P=0.019), longer test duration (0.84, P<0.001) and worsening symptoms (0.55, P=0.001) than the questionnaires. FENO had a more favourable assessment but was assessed to be difficult to perform. Inhaler technique received the most favourable assessment. Conclusions: Older adults hold favourable perceptions to a range of tests that they might encounter in the course of their care for airway disease. The newer tests of sputum induction and FENO have some observed difficulties, in particular sputum induction. The results of this study can inform current practice by including details of the test and its associated adverse effects when conducting the test, as well as providing clear explanations of the utility of tests and how the results might aid in patient care.]]> Tue 26 Jun 2018 11:28:14 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23969 Thu 28 Oct 2021 13:03:18 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20255 Sat 24 Mar 2018 07:59:56 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:49696 Mon 29 May 2023 12:46:49 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31921 Mon 23 Sep 2019 10:59:24 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46178 Mon 14 Nov 2022 15:55:52 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:46175 Mon 14 Nov 2022 15:50:19 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42246 P = 0.001) was associated with increased odds (OR = 4.5) of being offered biobanking. The majority did not know what occurred to samples after surgery (59.3%) or pathology review (81.4%) and ability to answer these questions was associated with discussion of participation (P < 0.001). Of the few outpatients who discussed biobanking with their doctor (29%), all consented. Conclusion: Professional‐initiated, opt‐in consent resulted in a few educated patients being approached; greater professional initiation of consent would be fruitful as most patients were willing to participate if asked. However, other consent approaches minimizing professional involvement were as acceptable to participants warranting further consideration.]]> Fri 26 Aug 2022 09:40:53 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38187 Fri 22 Apr 2022 13:52:10 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:53086 Fri 17 Nov 2023 11:34:27 AEDT ]]>